HOB Biotech Group Corp Ltd (688656) — Cash Flow Quality Index
HOB Biotech Group Corp Ltd (688656) has a Cash Flow Quality Index of 2.45x as of September 2025. Operating cash flow of CN¥34.39 Million exceeds net income of CN¥14.02 Million, indicating high earnings quality where cash backs reported profits. Also explore HOB Biotech Group Corp Ltd asset portfolio for the complete picture of this company's asset base.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
HOB Biotech Group Corp Ltd Cash Flow Quality Index (2016–2024)
Historical Cash Flow Quality Index for HOB Biotech Group Corp Ltd across 9 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check how tangible is HOB Biotech Group Corp Ltd's equity to evaluate the tangible quality of the company's equity base.
Annual Cash Flow Quality Index for HOB Biotech Group Corp Ltd (2016–2024)
Year-by-year earnings quality comparison for HOB Biotech Group Corp Ltd. For live market cap and the full company financial profile, see HOB Biotech Group Corp Ltd market cap and net worth.
| Year | Quality Index | Operating CF (CNY) | Net Income | YoY Change |
|---|---|---|---|---|
| 2024 | 2.75x | CN¥101.22 Million | CN¥36.80 Million | ▲ +26.8% |
| 2023 | 2.17x | CN¥102.69 Million | CN¥47.33 Million | ▲ +55.0% |
| 2022 | 1.40x | CN¥58.31 Million | CN¥41.65 Million | ▲ +15.1% |
| 2021 | 1.22x | CN¥104.79 Million | CN¥86.19 Million | ▲ +18.2% |
| 2020 | 1.03x | CN¥58.22 Million | CN¥56.62 Million | ▼ -4.3% |
| 2019 | 1.07x | CN¥68.57 Million | CN¥63.84 Million | ▼ -7.3% |
| 2018 | 1.16x | CN¥46.51 Million | CN¥40.15 Million | ▲ +11.1% |
| 2017 | 1.04x | CN¥22.26 Million | CN¥21.35 Million | ▼ -29.6% |
| 2016 | 1.48x | CN¥6.42 Million | CN¥4.34 Million | — |